Improvement of Production System of Domestic Diagnostic Preparation «Lantavist»

Authors

  • Yu.V. Korovin
  • N.V. Rusakova
  • S.S. Smola
  • I.M. Grigorasheva

DOI:

https://doi.org/10.15407/scin6.06.031

Keywords:

compounds of gadolinium, diagnostic means, identification, magnetic-contrast substances

Abstract

With the help of improved technique the basic chemical component of gadolinium diethylenetriaminepentaacetate preparation substance is obtained. The additional methods (spectrophotometry and luminescent) of control of substance components’ and medicinal form’s (indicated complex with D(-)-N-methylglucamine) quality are developed. The technological line of preparation overflow resulting in diminishing of its production losses is improved.

References

Lauterbur P.C., Medonca-Dias M.H., Rudin A.M. Augmentation of tissue water protein spin-lattice relaxation rates by in vivo addition of paramegnetic ions. Front. Biol. Engin. 1978. V. 1. P. 752-759.

Babij Ja.S., Demin V.T. Sostojanie i perspektivy razvitija MRT v Ukraine. Med. vesti. 1999. No 1: 36-38 [in Russian].

Weinmann H.-J., Brasch R.C., Press W.R., Wesbey G.E. Characteristics of gadolinium-DTPA complex: a potencial NMR contrast agent. Amer. J. Roengenol. 1984. V. 142. P. 619-624.

https://doi.org/10.2214/ajr.142.3.619

Carr D.H., Brown G., Bydder G.M., et all. Intravenous chelated gadolinium as a contrast agent in NMR imaging of cerebral tumors. Lancet. 1984. V. 3. P. 484-486.

https://doi.org/10.1016/S0140-6736(84)92852-6

Sergeev P.V., Bolotova E.N., Korovin Ju.V. i dr. Azaciklicheskij piridinsoderzhashhij kompleks gadoli nija kak perspektivnyj paramagnitnyj kont rastnyj agent v magnitnorezonansnoj tomografii. Him.-farm. zhurn. 1996. No 3: 21-22 [in Russian].

Patent Ukrai'ny N 6177, A61K 49/00. Sposib oderzhannja zasobu dlja magnitno-rezonansnoi' tomografii'. Ju.V. Korovin, N.V. Rusakova, S.M. Chesnov, V.V. Gorashhenko [in Ukrainian].

Korovin Yu., Popkov Yu., Rusakova N. Luminescence of gadolinium complexes with 1,4,7,10-tetraaza-2,6-py ridinophane[12]-1,4,7-triacetic acid. Mendeleev Commun. 1996. V. 1. P. 7-8.

https://doi.org/10.1070/MC1996v006n01ABEH000553

Laniado M., Weinmann H.-J., Schurner W., et all. First use of Gd-DTPA. Dimeglumine in man. Physiol. Chem. and Phys. and Med. NMR. 1984. V. 16. P. 157-165.

Weinreb J.C., Devis S.D., Berkmen Y.M. Pulmonary artery sarcoma: evalution using Gd-DTPA. J. Comput. As sist. Tomography. 1990. V. 14. P. 647-649.

https://doi.org/10.1097/00004728-199007000-00025

Brechbiel MW., Gansow O.A., Atcher R.W., et all. Synthesis of 1-(p-isothiocyanatobenzyl) derivatives of DTPA and EDTA. Antibody labeling and tumor-imaging studies. Inorg. Chem. 1986. V. 25. P. 2772-2781.

https://doi.org/10.1021/ic00236a024

Korovin Yu., Popkov Yu., Rusakova N. Luminescence of ga dolinium complexes with 1,4,7,10-tetraaza-2,6-py ridinophane[12]-1,4,7-triacetic acid. Mendeleev Commun. 1996. V. 1. P. 7-8.

https://doi.org/10.1070/MC1996v006n01ABEH000553

Published

2024-05-30

Issue

Section

Research and Engineering Innovative Projects of the National Academy of Sciences of Ukraine